Autolus Funding: $1.2B Raised, IPO (2021)

Autolus funding overview

Autolus is based in London, United Kingdom. Autolus has raised $1.2B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is an IPO announced in January 2021. The round record for Autolus runs through 2021; nothing later has been disclosed. Investors on record include Syncona Ltd, Woodford Investment Management, Perceptive Bioscience Investments, Cormorant Asset Management, Nextech Invest, Arix Bioscience and 1 others. 7 distinct backers are named across the disclosed rounds.

Autolus at a glance

Total raised: $1.2B
Latest round: IPO
Latest round date: January 2021
Headquarters: London, United Kingdom
Notable investors: Syncona Ltd, Woodford Investment Management, Perceptive Bioscience Investments, Cormorant Asset Management, Nextech Invest, Arix Bioscience, BioNTech

Frequently asked about Autolus funding

How much has Autolus raised?: Autolus has raised $1.2B in total disclosed funding across the rounds on record.
Who has invested in Autolus?: Syncona Ltd, Woodford Investment Management, Perceptive Bioscience Investments, Cormorant Asset Management, Nextech Invest, Arix Bioscience are named among the investors backing Autolus.
What was the latest Autolus funding round?: The most recent disclosed round is an IPO, announced in January 2021.
Where is Autolus based?: Autolus is based in London, United Kingdom.
When did Autolus last raise?: The last disclosed Autolus round closed in January 2021 at IPO.

Round data for Autolus is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in London and backer lists below.

Autolus Funding: $1.2B Raised, IPO (2021)

Autolus funding overview

Autolus at a glance

Frequently asked about Autolus funding

Companies related to Autolus (19)

Browse related funding lists (7)